Furthermore, indicators of myocardial fibrosis, such as serum sST2 and Gal3, ECV, and iECV, were shown to be independent predictors of unfavorable endpoints in HFpEF patients (51–54). This evidence concerns the gene LGALS3 and Myocardial fibrosis.